Encyclopedia / Body composition

Tesamorelin 5 mg.

Achieve up to 20% visceral fat reduction with targeted GHRH signaling.

Body compositionGH axisSubcutaneous or intramuscular injection

Build a stack with Tesamorelin 5 mg Buy on catalog

Evidence

What the research shows

In clinical studies, tesamorelin has demonstrated a significant 15-20% reduction in visceral fat over a 26-week period at a dosage of 2 mg/day. This GHRH analog also leads to an impressive increase in IGF-1 levels, averaging +81%. Its mechanism involves the activation of GHRH receptors, which stimulates downstream hormonal pathways crucial for metabolic health. While primarily studied in non-human models, the pharmacokinetic profiles indicate promising applications in endocrine research.

Protocol

Cycle and dosing notes

For optimal results, administer 2 mg of tesamorelin subcutaneously once daily. Maintain this dosage for a continuous cycle of 26 weeks. Monitor your body's response closely, and consult your research protocols for any required adjustments or breaks in administration.

Safety

What to watch for

Not medical advice. Tesamorelin is intended strictly for laboratory experimentation and is not approved for human consumption outside authorized research protocols. Side effects may include injection site reactions, and it is essential to monitor for any unexpected physiological responses during use.

Best for

Who benefits most

Ideal for researchers and biohackers focused on metabolic health and endocrine signaling. If you're exploring the intricate pathways of growth hormone regulation and its effects on body composition, tesamorelin offers a powerful tool for your investigations.

Not for

Who should avoid it

Not for individuals seeking medical treatment or those with a history of hypersensitivity to GHRH analogs.

Build your stack

Tesamorelin 5 mg works best inside a protocol.

Pepzilla matches it with the right companions, dosing, and lifestyle rails for your goals — calibrated in 60 seconds.

Build my stack Browse encyclopedia